Overview

  • Product nameSalsolinol hydrochloride
  • Description
    Dopamine derivative
  • Biological descriptionDopamine (ab120565) derivative. Putative endogenous opioid system-activating factor. Antagonizes L-DOPA-mediated hyperactivity. Shows central effects in vivo.
  • Purity> 99%

Properties

    References for Salsolinol hydrochloride (ab120603)

    This product has been referenced in:
    • Mozdzen E  et al. Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system. Neurotox Res 27:300-13 (2015). Read more (PubMed: 25537852) »
    • Wasik A  et al. Chronic Salsolinol Administration Prevents the Behavioral and Neurochemical Effects of L-DOPA in Rats. Neurotox Res 27:399-410 (2015). Read more (PubMed: 25711629) »
    • Zhu W  et al. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease. Clin Chem 54:705-12 (2008). Read more (PubMed: 18238832) »
    • Mravec B Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiol Res 55:353-64 (2006). Read more (PubMed: 16238467) »
    • Naoi M  et al. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology 25:193-204 (2004). Read more (PubMed: 14697894) »
    • Matsuzawa S  et al. Involvement of mu-opioid receptor in the salsolinol-associated place preference in rats exposed to conditioned fear stress. Alcohol Clin Exp Res 24:366-72 (2000). Read more (PubMed: 10776678) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120603.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"